Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.79%
SPX
-1.13%
IXIC
-1.30%
FTSE
-0.39%
N225
-0.89%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Nektar Therapeutics News

businesswire.com

Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer

Feature Image for interests on ETF, Healthcare, Stock, Unknown Sector from businesswire.com
4 months ago
prnewswire.com

Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Feature Image for interests on Acquisitions, Biotechnology, Energy, Health Care & Hospitals from prnewswire.com
6 months ago
finance.yahoo.com

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Feature Image for interests on Alopecia Areata, Atopic Dermatitis, Healthcare, Inflammatory Conditions from finance.yahoo.com
9 months ago
businesswire.com

ReAlta Life Sciences Further Bolsters Experienced Executive Team with the Appointment of Peter Ho, Ph.D., as Head of Business Development and Corporate Strategy

Feature Image for interests on ETF, Healthcare, Stock, Unknown Sector from businesswire.com
9 months ago
finance.yahoo.com

Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award

Feature Image for interests on Healthcare, Instatin, Investment Partner, John Patton from finance.yahoo.com
9 months ago
finance.yahoo.com

Nektar Management to Present at Upcoming Investor Conferences

Feature Image for interests on Healthcare, Investment Conference, Investor Conferences, Nektar Therapeutics from finance.yahoo.com
9 months ago
finance.yahoo.com

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance

Feature Image for interests on Biotechnology Company, Company, Corporate Quality, Forward-Looking Statement from finance.yahoo.com
10 months ago
finance.yahoo.com

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Feature Image for interests on Earnings Per Share, Healthcare, Nektar Therapeutics, Pharmaceuticals Industry from finance.yahoo.com
10 months ago
finance.yahoo.com

Nektar: Q2 Earnings Snapshot

Feature Image for interests on Automated Insights, Healthcare, Nektar Therapeutics, San Francisco from finance.yahoo.com
10 months ago
finance.yahoo.com

Nektar Therapeutics Reports Second Quarter 2024 Financial Results

Feature Image for interests on Alopecia Areata, Atopic Dermatitis, Healthcare, Nektar Therapeutics from finance.yahoo.com
10 months ago
Stocks
Health Care
nktr
Nektar Therapeutics
NKTR
-0.19 (-2.17%)
8.57
USD
At close at Jun 13, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Nektar Therapeutics: Aro Biotherapeutics Appoints New CEO to Enhance siRNA Drug Development

4 months ago
publisher logo
Cashu

Nektar Therapeutics: Aro Biotherapeutics' Leadership Change Signals New Strategic Direction

4 months ago
publisher logo
Cashu

Nektar Therapeutics Transfers PEGylation Business to Gannet BioChem for Strategic Focus Shift

6 months ago